Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.
A B GottliebJ F MerolaKristian ReichF BehrensP NashChristopher Ernest Maitland GriffithsW BaoP PelletL PricopI B McInnesPublished in: The British journal of dermatology (2021)
This prespecified analysis in PsA patients with concomitant moderate-to-severe plaque psoriasis in the EXCEED study provides further evidence that IL-17 inhibitors offer a comprehensive biological treatment to manage the concomitant features of psoriasis and PsA.